Ameritas Investment Partners’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-15,149
Closed -$38.3K 3111
2023
Q4
$38.3K Hold
15,149
﹤0.01% 2303
2023
Q3
$36.2K Buy
15,149
+3,925
+35% +$8.69K ﹤0.01% 2269
2023
Q2
$25.9K Hold
11,224
﹤0.01% 2422
2023
Q1
$28.6K Hold
11,224
﹤0.01% 2307
2022
Q4
$37.8K Hold
11,224
﹤0.01% 2249
2022
Q3
$32K Hold
11,224
﹤0.01% 2275
2022
Q2
$50K Buy
+11,224
New +$66.8K ﹤0.01% 1987

Ameritas Investment Partners's SLGC Position: Q1 2024 in Review

Ameritas Investment Partners sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 15,149 shares — an estimated $38.3K sold.

Ameritas Investment Partners first reported a position in SLGC in Q2 2022 and held it in 7 quarters. The position peaked at $50K in Q2 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • Ameritas Investment Partners reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 15,149 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $38.3K.
  • Ameritas Investment Partners first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 7 quarters.
  • Ameritas Investment Partners's SomaLogic, Inc. Class A Common Stock position peaked at $50K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Ameritas Investment Partners's 13F filing for Q1 2024, filed 13 May 2024.